データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced From Linea DNA
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
10-K:有価証券報告書
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
8-K:Applied DNAが第4四半期と2024会計年度の決算を発表、遺伝子医薬品の重要な出発物質の製造を優先するための戦略的再編を発表
データなし